9 Best Biotech Penny Stocks to Buy in 2026
On April 24, Drew Pettit, Citi US equity strategist, joined 'The Exchange' on CNBC to discuss the market fundamentals this year, with a positive outlook for the market as investors look past geopolitical...
Mimedx Group Inc. (MDXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trigran Investments Douglas T. Granat | 7,175,109 | $28,341,680 | +17% | 6.78% |
| 2. | Renaissance Technologies Jim Simons | 3,019,871 | $11,928,490 | +23% | 0.02% |
| 3. | Meros Investment Management Timothy Chatard | 1,093,028 | $4,317,461 | -18% | 1.87% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 775,841 | $3,064,572 | +24% | 0% |
| 5. | Fisher Asset Management Ken Fisher | 246,569 | $973,947 | +1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.34 | 200,000 | $1,268,000.00 | 529,530 | 2025-05-02 | Filing | |
| $7.16 | 5,000 | $35,786.50 | 102,200 | 2023-11-21 | Filing | |
| $6.50 | 42,025 | $273,330.60 | 100,000 | 2023-06-23 | Filing | |
| $6.33 | 57,975 | $367,103.50 | 57,975 | 2023-06-22 | Filing | |
| $6.99 | 20,000 | $139,800.00 | 5,009,121 | 2016-05-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.42 | 58,300 | $432,329.48 | 236,982 | 2025-11-06 | Filing | |
| $8.04 | 1,759 | $14,142.36 | 309,077 | 2025-03-17 | Filing | |
| $7.89 | 20,366 | $160,687.74 | 440,178 | 2025-03-13 | Filing | |
| $7.89 | 34,230 | $270,074.70 | 460,544 | 2025-03-13 | Filing | |
| $7.89 | 4,106 | $32,396.34 | 310,836 | 2025-03-13 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,195,249 | $111,371,234 | 44.45% | |
| 2. | 11,911,300 | $47,049,635 | 0% | |
| 3. | 5,166,006 | $20,405,724 | 0% | |
| 4. | 3,410,300 | $13,470,685 | 0.52% | |
| 5. | 2,694,002 | $10,640,482 | 0% |
News See All
10 Oversold Small Cap Stocks to Buy Now
In this article, we will take a look at some of the most oversold small-cap stocks that currently offer attractive upside to investors. On April 18, stocks in the U.S.
Citizens Lowers MiMedx Group, Inc. (MDXG) Valuation to $7 Amid Sluggish Recovery Trends
TheFly reported on April 20 that Citizens Financial Group lowered its price target on MDXG from $10 to $7 while maintaining an Outperform rating.
9 Most Undervalued Healthcare Stocks to Buy Now
On April 17, Matt Powers, managing partner at Powers Advisory Group, appeared on CNBC’s Squawk Box to discuss the forces shaping current market behavior.
MiMedx Group (MDXG) Delivers Record Full Year Revenue
MiMedx Group, Inc. (NASDAQ:MDXG) is one of the Best 52-Week Low Penny Stocks to Invest In. On February 25, MiMedx Group, Inc.
11 Best 52-Week Low Penny Stocks to Invest In
On January 14, Eddie Ghabour, co-founder of Key Advisors Group LLC, appeared on a Schwab Network interview to discuss his bullish outlook for small-cap stocks.
Craig-Hallum Adjusts MiMedx Group, Inc. (MDXG) Outlook on CMS Coverage Guidance
TheFly reported on January 23 that Craig-Hallum analyst Chase Knickerbocker lowered the price target on MDXG to $10 from $13 and maintained a Buy rating.
20 Best Biotech Stocks Under $20 to Buy Now
The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2025 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter 2025 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy
MiMedx Group, Inc. (NASDAQ:MDXG) is a biotechnology company based in Marietta, Georgia, specializing in regenerative biologics for advanced wound care and surgical recovery.
Hedge Fund Resource Center